Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of DA001 eye drops for slowing myopia progression in children
CTR20250055Phase 2Active
- Sponsor
- Grand Life Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA001 in myopia, sponsored by Grand Life Sciences. Started Jan 2025; status: active.
02
Drugs
DA001
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20250055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250055.